Autoinflammatory diseases and cardiovascular manifestations

References

• Rigante D. The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration. Eur Rev Med Pharmacol Sci. 2010;14:1–18.
   PubMed Web of Science ®Google Scholar
• Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology. 2004;43: 410–5.
   PubMed Web of Science ®Google Scholar
• Guz G, Kanbay M, Ozturk MA. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009;22: 309–15.
   PubMed Web of Science ®Google Scholar
• Stehlik C, Reed JC. The pyrin connection: novel players in innate immunity and inflammation. J Exp Med. 2004;200: 551–8.
   PubMed Web of Science ®Google Scholar
• Papadopoulos VP, Giaglis S, Mitroulis I, Ritis K. The population genetics of familial Mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72(Pt 6):752–61.
   PubMedGoogle Scholar
• Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM, . Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum. 2009;60:1851–61.
   PubMedGoogle Scholar
• Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, . Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746–50.
   PubMed Web of Science ®Google Scholar
• Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, . International Study Group for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007; 56:1706–12.
   PubMed Web of Science ®Google Scholar
• Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.
   PubMed Web of Science ®Google Scholar
• Eliakim M, Ehrenfeld EN. Electrocardiographic changes in recurrent polyserositis (‘periodic disease’). Am J Cardiol. 1961; 7:517–20.
   PubMedGoogle Scholar
• Dabestani A, Noble LM, Child JS, Krivokapich J, Schwabe AD. Pericardial disease in familial Mediterranean fever: an echocardiographic study. Chest. 1982;81:592–5.
   PubMed Web of Science ®Google Scholar
• Zimaud S, Tauber T, Hegesch T, Aladjen M. Familial Mediterranean fever presenting with massive cardiac tamponade. Clin Exp Rheumatol. 1994;12:67–9.
   PubMedGoogle Scholar
• Kees S, Langevitz P, Zemer D, Padeh S, Pras M, Livneh A. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM. 1997;90:643–7.
   PubMed Web of Science ®Google Scholar
• Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, . Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine. 2005;84:1–11.
   PubMed Web of Science ®Google Scholar
• Tutar E, Yalçinkaya F, Özcaya N, Ekim M, Atalay S. Incidence of pericardial effusion during attacks of familial Mediterranean fever. Heart. 2003;89:1257–8.
   PubMedGoogle Scholar
• Okutur K, Seber S, Oztekin E, Bes C, Borlu F. Recurrent pericarditis as the initial manifestation of familial Mediterranean fever. Med Sci Monit. 2008;14:CS139–41.
   PubMed Web of Science ®Google Scholar
• Tutar HE, Imamoglu A, Kendirli T, Akar E, Atalay S, Akar N. Isolated recurrent pericarditis in a patient with familial Mediterranean fever. Eur J Pediatr. 2001;160:264–5.
   PubMed Web of Science ®Google Scholar
• Ozen S. Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol. 2009;27(Suppl 53):S29–31.
   Google Scholar
• Tekin M, Yalçinkaya F, Tümer N, Cakar N, Koçak H. Familial Mediterranean fever and acute rheumatic fever: a pathogenetic relationship? Clin Rheumatol. 1999;18:446–9.
   PubMedGoogle Scholar
• Tutar E, Akar N, Atalay S, Yilmaz E, Akar E, Yalçinkaya F. Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease. Heart. 2002;87:568–9.
   PubMedGoogle Scholar
• Grimaldi MP, Candore G, Vasto S, Caruso M, Caimi G, Hoffmann E, . Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. J Leukoc Biol. 2006;79: 611–5.
   PubMedGoogle Scholar
• Akcay A, Acar G, Sayarlioglu M, Sokmen A, Kaya H, Ispiroglu M, . QT dispersion and transmural dispersion of repolarization in patients with familial Mediterranean fever. Mod Rheumatol. 2009;19:550–5.
   PubMed Web of Science ®Google Scholar
• Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, . Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010;48:407–14.
   PubMed Web of Science ®Google Scholar
• Halwani O, Delgado DH. Cardiac amyloidosis: an approach to diagnosis and management. Expert Rev Cardiovasc Ther. 2010;8:1007–13.
   PubMedGoogle Scholar
• McDermott EM, Smillie DM, Powell RJ. Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family. Mayo Clin Proc. 1997;72: 806–17.
   PubMed Web of Science ®Google Scholar
• Dodé C, André M, Bienvenu T, Hausfater P, Pêcheux C, Bienvenu J, . French Heraditary Recurrent Inflammatory Disorder Study Group. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2002;46: 2181–8.
   PubMed Web of Science ®Google Scholar
• Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK, . Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48:2632–44.
   PubMed Web of Science ®Google Scholar
• Stojanov S, McDermott MF. The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med. 2005;7:1–18.
   PubMedGoogle Scholar
• Cantarini L, Lucherini OM, Baldari CT, Laghi Pasini F, Galeazzi M. Familial clustering of recurrent pericarditis may disclose tumour necrosis-factor receptor-associated periodic syndrome. Clin Exp Rheumatol. 2010;28:405–7.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Bellisai F, Rossi Paccani S, . Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor associated periodic syndrome. Int J Immunopathol Pharmacol. 2009;22:1051–8.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Cimaz R, Galeazzi M. Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol. 2010;28:802.
   PubMed Web of Science ®Google Scholar
• Trost S, Rosé CD. Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol. 2005;32:175–7.
   PubMed Web of Science ®Google Scholar
• Roubille F, Cayla G, Gahide G, Mourad G, Macia JC. Acute myocarditis and tumor necrosis factor receptor-associated periodic (TRAP) syndrome: first case described and discussion. Eur J Int Med. 2009;20:e25–6.
   Google Scholar
• Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky BH, . Clinical and functional characterisation of a novel TNFRSF1A c.605T > A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis. 2008;67:1292–8.
   PubMedGoogle Scholar
• Chia S, Qadan M, Newton R, Ludlam CA, Fox KA, Newby DE. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans. Arterioscler Thromb Vasc Biol. 2003;23:695–701.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Cimaz R, Brizi MG, Galeazzi M. Serosal involvement in adult-onset autoinflammatory disorders. Respiration. 2010;80:260–1.
   PubMedGoogle Scholar